Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2020 Jun;9(3):983-985.
doi: 10.21037/tau.2020.04.03.

Optimizing frontline therapy in advanced urothelial cancer

Whi-An Kwon  1 , Ho Kyung Seo  2
Affiliations
Editorial

Optimizing frontline therapy in advanced urothelial cancer

Whi-An Kwon et al. Transl Androl Urol. 2020 Jun.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: Both authors have completed the ICMJE uniform disclosure from (available at http://dx.doi.org/10.21037/tau.2020.04.03). The authors have no conflicts of interest to declare.

Comment on

References

    1. Galsky MD, Hahn NM, Rosenberg J, et al. Treatment of patients with metastatic urothelial cancer "unfit" for cisplatin-based chemotherapy. J Clin Oncol 2011;29:2432-8. 10.1200/JCO.2011.34.8433 - DOI - PubMed
    1. Witjes JA, Babjuk M, Bellmunt J, et al. EAU-ESMO consensus statements on the management of advanced and variant bladder cancer-an international collaborative multistakeholder effort: under the auspices of the EAU-ESMO guidelines committees. Eur Urol 2020;77:223-50. 10.1016/j.eururo.2019.09.035 - DOI - PubMed
    1. Calabro F, Lorusso V, Rosati G, et al. Gemcitabine and paclitaxel every 2 weeks in patients with previously untreated urothelial carcinoma. Cancer 2009;115:2652-9. 10.1002/cncr.24313 - DOI - PubMed
    1. Meluch AA, Greco FA, Burris HA, 3rd, et al. Paclitaxel and gemcitabine chemotherapy for advanced transitional cell carcinoma of the urothelial tract: a phase II trial of the Minnie pearl cancer research network. J Clin Oncol 2001;19:3018-24. 10.1200/JCO.2001.19.12.3018 - DOI - PubMed
    1. Galsky MD, Chen GJ, Oh WK, et al. Comparative effectiveness of cisplatin-based and carboplatin-based chemotherapy for treatment of advanced urothelial carcinoma. Ann Oncol 2012;23:406-10. 10.1093/annonc/mdr156 - DOI - PubMed